NEW YORK, LONDON, BERLIN, and PARIS, November 18, 2014 /PRNewswire/ --
Reportstack has announced the publication of market research report on Global Pulmonary Drug Delivery Systems Market which is expected to grow at a CAGR of 8.90 percent from 2015-2019. An increase in the prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) is expected to expand the patient population for pulmonary drug delivery systems in the coming years. Subsequently, this is also expected to increase the market revenue for these drug delivery systems.
Complete report is available @ http://www.reportstack.com/product/185613/global-pulmonary-drug-delivery-systems-market-2015-2019.html
About Pulmonary Drug Delivery Systems:
Pulmonary delivery of drugs leads to the deposition of drugs in the lungs and subsequent local or systemic therapeutic activity. The pulmonary route of administration for the non-invasive delivery of drugs is mostly preferred because of the large surface area for absorption, high blood circulation, and high permeability rate. Pulmonary drug delivery offers various advantages over peroral routes, such as bypass of hepatic first-pass metabolism, quick onset of action, and low enzymatic activity.
Pulmonary delivery of drugs can be achieved by intranasal administration or oral inhalative administration, the latter being more effective. Oral inhalative administration includes intratracheal inhalation and intratracheal instillation. Oral inhalation delivers the aerosolized drug using devices such as MDIs (or pMDIs), PDIs, and nebulizers. Drugs administered by this route are deposited in the respiratory tract via inertial impaction, gravitational sedimentation, and diffusion. The effective delivery of drugs via the pulmonary route requires an optimized combination of drug, its formulation, and device.
The new report from Reportstack emphasizes vendors that are increasing their online marketing and promotional activities so as to provide better product accessibility to customers and gain more sales. Online marketing services also allow vendors to minimize setup, distribution and operational costs.
"A number of small and large vendors sell nebulizers and their accessories online, thus making them convenient for consumers to obtain. The vendors also provide discounts or promotional offers online, which have increased the number of online purchases," says Faisal Ghaus, Vice President of TechNavio.
There are no time limits for product availability when purchasing a product online, as compared to medical supply stores. The products offered on online stores are authentic and also come with a warranty from the manufacturer.
Increase in Prevalence and Incidence of Respiratory Diseases is the key market driver and Increase in Online Marketing Services is the market trend. For full list of market drivers, market challenges and market trends please visit pulmonary drug delivery systems market.
What is covered in this report?
This report covers the present scenario and the growth prospects of the Global Pulmonary Drug Delivery Systems market for the period 2015-2019. To calculate the market size, the report considers the revenue from the sales of various pulmonary drug delivery systems intended for oral inhalation including: MDIs (or pMDIs), DPIs and Nebulizers. Americas, APAC and EMEA are the key regions covered in this report.
AstraZeneca plc, GlaxoSmithKline plc, Philips Healthcare, 3M Health Care, Actelion Pharmaceuticals, Carefusion, Aerogen, Airon, Briggs healthcare, Allied healthcare products, Clement Clarke International, DeVilbiss Healthcare, Drive Medical Design and Manufacturing, GF Health Products, Heyer Medical, OMRON, PARI Medical Holding, Salter Labs and Teleflex are the key vendors mentioned in this report.
Other Reportstack's Drug Delivery Market Reports:
Reportstack is one of the leading distributors of market research reports in the world today. Reportstack provides access to over 50,000 company profiles and their strategic information like SWOT analysis, deals and partnerships analysis, merger & acquisition activity and new product launches. Reportstack is also a leader in the field of Pharma partnership deals and competitor analysis & Medical Devices Market Research Reports.
Sr. Marketing Executive
Reportstack Market Research
Phone: +1 888-789-6604
SOURCE M/S. Reportstack